| Report ID | Date of report | Patient age | Patient gender |
| 42020 | Feb, 9, 2006 | 38 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Accutane | isotretinoin |
Demulen 1/35-21 | ethinyl estradiol; ethynodiol diacetate |
| Name |
Abdominal Pain |
Abdominal Pain Upper |
Acrochordon |
Amblyopia |
Arthralgia |
Arthropathy |
Behcet's Syndrome |
Bone Pain |
C-reactive Protein Increased |
Colitis |
Colon Adenoma |
Crohn's Disease |
Defaecation Urgency |
Depression |
Diarrhoea |
Disorientation |
Dizziness |
Erythema Nodosum |
Eye Irritation |
Eye Pain |
Eye Pruritus |
Fatigue |
Gastrointestinal Disorder |
Granuloma |
Haemoglobin Decreased |
Haemorrhoids |
Inflammation |
Inflammatory Bowel Disease |
Intestinal Haemorrhage |
Intraocular Pressure Increased |
Multi-organ Disorder |
Ocular Hyperaemia |
Oral Mucosa Erosion |
Photophobia |
Platelet Count Increased |
Rectal Haemorrhage |
Rectal Polyp |
Red Blood Cell Count Decreased |
Red Blood Cell Sedimentation Rate Decreased |
Treatment Noncompliance |
Vaginal Ulceration |
Vision Blurred |
Visual Acuity Reduced |
Results from eHealthMe : 60 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Abdominal Pain | 1 (1.67%) |
Abdominal Pain Upper | 2 (3.33%) |
Acrochordon | 4 (6.67%) |
Amblyopia | 1 (1.67%) |
Arthralgia | 12 (20.00%) |
Arthropathy | 1 (1.67%) |
Behcet's Syndrome | 3 (5.00%) |
Bone Pain | 2 (3.33%) |
C-reactive Protein Increased | 1 (1.67%) |
Colitis | 19 (31.67%) |
Colon Adenoma | 2 (3.33%) |
Crohn's Disease | 21 (35.00%) |
Defaecation Urgency | 2 (3.33%) |
Depression | 22 (36.67%) |
Diarrhoea | 1 (1.67%) |
Disorientation | 1 (1.67%) |
Dizziness | 2 (3.33%) |
Erythema Nodosum | 5 (8.33%) |
Eye Irritation | 2 (3.33%) |
Eye Pain | 3 (5.00%) |
Eye Pruritus | 1 (1.67%) |
Fatigue | 4 (6.67%) |
Gastrointestinal Disorder | 13 (21.67%) |
Granuloma | 3 (5.00%) |
Haemoglobin Decreased | 1 (1.67%) |
Haemorrhoids | 5 (8.33%) |
Inflammation | 2 (3.33%) |
Inflammatory Bowel Disease | 31 (51.67%) |
Intestinal Haemorrhage | 19 (31.67%) |
Intraocular Pressure Increased | 1 (1.67%) |
Multi-organ Disorder | 7 (11.67%) |
Ocular Hyperaemia | 2 (3.33%) |
Oral Mucosa Erosion | 1 (1.67%) |
Photophobia | 2 (3.33%) |
Platelet Count Increased | 3 (5.00%) |
Rectal Haemorrhage | 12 (20.00%) |
Rectal Polyp | 6 (10.00%) |
Red Blood Cell Count Decreased | 1 (1.67%) |
Red Blood Cell Sedimentation Rate Decreased | 1 (1.67%) |
Treatment Noncompliance | 1 (1.67%) |
Vaginal Ulceration | 1 (1.67%) |
Vision Blurred | 3 (5.00%) |
Visual Acuity Reduced | 2 (3.33%) |
Top 3 (total: 44. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Prilosec | 8 (4.00%) |
Demulen 1/35-28 | 8 (4.00%) |
Demulen (ethinyl Estradiol/ethynodiol Diacetate) | 6 (3.00%) |
Death reported: 0
| Name | Count (% of total reports) |
Inflammatory Bowel Disease | 31 (51.67%) |
Depression | 22 (36.67%) |
Crohn's Disease | 21 (35.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
